115 related articles for article (PubMed ID: 6800794)
21. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer.
Számel I; Vincze B; Hindy I; Hermann I; Borvendég J; Eckhardt S
Oncology; 1986; 43(1):7-11. PubMed ID: 3079899
[TBL] [Abstract][Full Text] [Related]
22. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.
Ravdin PM; Fritz NF; Tormey DC; Jordan VC
Cancer Res; 1988 Feb; 48(4):1026-9. PubMed ID: 3123050
[TBL] [Abstract][Full Text] [Related]
23. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
24. Daily follicle-stimulating hormone, luteinizing hormone, estradiol, and progesterone in ten women harboring uterine leiomyomas.
Maheux R; Lemay-Turcot L; Lemay A
Fertil Steril; 1986 Aug; 46(2):205-8. PubMed ID: 3089842
[TBL] [Abstract][Full Text] [Related]
25. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
Bird CE; Cook S; Owen S; Sterns EE; Clark AF
Oncology; 1981; 38(6):365-8. PubMed ID: 6795556
[TBL] [Abstract][Full Text] [Related]
26. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
Bonte J
Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
[TBL] [Abstract][Full Text] [Related]
27. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects.
Helgason S
Acta Obstet Gynecol Scand Suppl; 1982; 107():1-29. PubMed ID: 6282033
[TBL] [Abstract][Full Text] [Related]
28. Comparison between tamoxifen and clomiphene therapy in women with anovulation.
Gerhard I; Runnebaum B
Arch Gynecol; 1979; 227(4):279-88. PubMed ID: 518130
[TBL] [Abstract][Full Text] [Related]
29. Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
Voipio SK; Komi J; Kangas L; Halonen K; DeGregorio MW; Erkkola RU
Maturitas; 2002 Nov; 43(3):207-14. PubMed ID: 12443837
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant therapy in uterine myoma].
Vikhliaeva EM
Vestn Ross Akad Med Nauk; 1997; (2):16-20. PubMed ID: 9376721
[TBL] [Abstract][Full Text] [Related]
31. Prolactin levels in menopausal women on long-term estrogen implants.
Goh HH; McCarthy TG; Dramusic V; Ratnam SS
Gynecol Endocrinol; 1989 Jun; 3(2):153-7. PubMed ID: 2510462
[TBL] [Abstract][Full Text] [Related]
32. Use of gonadotropin-releasing hormone agonists before myomectomy.
Friedman AJ
Clin Obstet Gynecol; 1993 Sep; 36(3):650-9. PubMed ID: 8403611
[No Abstract] [Full Text] [Related]
33. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315
[TBL] [Abstract][Full Text] [Related]
34. [Influence of the oral adminsitration of estrogens on serum gonadotropins and prolactin after the menopause].
Delvoye P; Vekemans M; Calaf J; L'Hermite M; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):357-9. PubMed ID: 4681545
[No Abstract] [Full Text] [Related]
35. [Hormonal response and therapeutic results in the use of tamoxifen in the induction of ovulation].
Bolis PF; Polatti F
Minerva Ginecol; 1981 Jan; 33(1):27-30. PubMed ID: 6787484
[No Abstract] [Full Text] [Related]
36. Pituitary gonadotrophins and prolactin in patients with endometrial cancer, fibroids or ovarian tumours.
Ylikorkala O; Kauppila A; Rajala T
Br J Obstet Gynaecol; 1979 Nov; 86(11):901-4. PubMed ID: 116672
[TBL] [Abstract][Full Text] [Related]
37. [Characteristics of hypophyseal gonadotropic hormone production and of the pathomorphological picture of the endometrium in hemorrhage in the postmenopause].
Donat J; Kopecný J; Jirkalová V
Akush Ginekol (Mosk); 1984 Feb; (2):33-5. PubMed ID: 6426334
[No Abstract] [Full Text] [Related]
38. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Ando M; Suzuki M
Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420
[TBL] [Abstract][Full Text] [Related]
39. Irritability in menopause: an investigation of its relation to menopausal, hormonal and physical factors.
Spyropoulou AC; Zervas IM; Christodoulakos G; Lambrinoudaki I; Rizos D; Koundi K; Sanida E; Creatsas G; Soldatos CR
Psychother Psychosom; 2009; 78(2):128-30. PubMed ID: 19223690
[No Abstract] [Full Text] [Related]
40. The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.
McFadyen IJ; Raab G; Forrest AP; Langlands AO; Stewart HJ; Roberts MM; Hamilton T; Golder MP; Groom GV; Griffiths K
Clin Oncol; 1979 Sep; 5(3):251-6. PubMed ID: 387323
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
